Works matching AU Nagai, Koji


Results: 34
    1

    Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis.

    Published in:
    Rheumatology, 2025, v. 64, n. 5, p. 2395, doi. 10.1093/rheumatology/keae603
    By:
    • Nishimura, Nozomi;
    • Onishi, Akira;
    • Yamamoto, Wataru;
    • Nagai, Koji;
    • Shiba, Hideyuki;
    • Okita, Yasutaka;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Okano, Takaichi;
    • Ueda, Yo;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yamada, Shinsuke;
    • Hashimoto, Motomu;
    • Maeda, Yuichi;
    • Onizawa, Hideo;
    • Fujii, Takayuki;
    • Murata, Koichi;
    • Murakami, Kosaku;
    • Tanaka, Masao
    Publication type:
    Article
    2

    Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-.

    Published in:
    PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194130
    By:
    • Ebina, Kosuke;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Ohnishi, Akira;
    • Kabata, Daijiro;
    • Hirano, Toru;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yoshida, Shuzo;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Akashi, Kengo;
    • Fujimura, Takanori;
    • Hirao, Makoto;
    • Yamamoto, Keiichi;
    • Shintani, Ayumi;
    • Kumanogoh, Atsushi;
    • Yoshikawa, Hideki
    Publication type:
    Article
    3
    4
    5
    6

    Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 5, p. 928, doi. 10.1093/mr/roac115
    By:
    • Hidehiko Makino;
    • Kotani, Takuya;
    • Hata, Kenichiro;
    • Nishioka, Daisuke;
    • Yamamoto, Wataru;
    • Yoshikawa, Ayaka;
    • Wada, Yumiko;
    • Hiramatsu, Yuri;
    • Shiba, Hideyuki;
    • Nagai, Koji;
    • Katayama, Masaki;
    • Yonsu Son;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Akashi, Kengo;
    • Hara, Ryota;
    • Hirano, Toru;
    • Hashimotoj, Motomu;
    • Takeuchia, Tohru
    Publication type:
    Article
    7

    The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 4, p. 834, doi. 10.1093/mr/roab043
    By:
    • Koichi Murata;
    • Ryuji Uozumi;
    • Motomu Hashimoto;
    • Kosuke Ebina;
    • Kengo Akashi;
    • Akira Onishi;
    • Koji Nagai;
    • Ayaka Yoshikawa;
    • Masaki Katayama;
    • Yonsu Son;
    • Hideki Amuro;
    • Ryota Hara;
    • Wataru Yamamoto;
    • Ryu Watanabe;
    • Kosaku Murakami;
    • Masao Tanaka;
    • Hiromu Ito;
    • Akio Morinobu;
    • Shuichi Matsuda
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.

    Published in:
    Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1673-1
    By:
    • Hashimoto, Motomu;
    • Furu, Moritoshi;
    • Yamamoto, Wararu;
    • Fujimura, Takanori;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Ohnishi, Akira;
    • Akashi, Kengo;
    • Yoshida, Shuzo;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Hirano, Toru;
    • Ebina, Kosuke;
    • Uozumi, Ryuji;
    • Ito, Hiromu;
    • Tanaka, Masao;
    • Ohmura, Koichiro;
    • Fujii, Takao;
    • Mimori, Tsuneyo
    Publication type:
    Article
    25

    Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-.

    Published in:
    PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216624
    By:
    • Ebina, Kosuke;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Hirano, Toru;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Onishi, Akira;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Yamamoto, Keiichi;
    • Maeda, Yuichi;
    • Murata, Koichi;
    • Jinno, Sadao;
    • Takeuchi, Tohru;
    • Hirao, Makoto;
    • Kumanogoh, Atsushi;
    • Yoshikawa, Hideki
    Publication type:
    Article
    26

    Association of large joint involvement at the start of biological disease‐modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.

    Published in:
    International Journal of Rheumatic Diseases, 2024, v. 27, n. 3, p. 1, doi. 10.1111/1756-185X.15097
    By:
    • Shirasugi, Iku;
    • Onishi, Akira;
    • Nishimura, Keisuke;
    • Yamamoto, Wataru;
    • Murakami, Kosaku;
    • Onizawa, Hideo;
    • Maeda, Yuichi;
    • Ebina, Kosuke;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Katayama, Masaki;
    • Hara, Ryota;
    • Nagai, Koji;
    • Hiramatsu, Yuri;
    • Hashimoto, Motomu;
    • Okano, Tadashi;
    • Maeda, Toshihisa;
    • Hayashi, Shinya;
    • Sendo, Sho;
    • Jinno, Sadao
    Publication type:
    Article
    27

    Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7399, doi. 10.3390/ijms24087399
    By:
    • Shiba, Hideyuki;
    • Kotani, Takuya;
    • Nagai, Koji;
    • Hata, Kenichiro;
    • Yamamoto, Wataru;
    • Yoshikawa, Ayaka;
    • Wada, Yumiko;
    • Hiramatsu, Yuri;
    • Makino, Hidehiko;
    • Ueda, Yo;
    • Onishi, Akira;
    • Murata, Koichi;
    • Amuro, Hideki;
    • Son, Yonsu;
    • Hara, Ryota;
    • Hirano, Toru;
    • Ebina, Kosuke;
    • Katayama, Masaki;
    • Hashimoto, Motomu;
    • Takeuchi, Tohru
    Publication type:
    Article
    28

    Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-.

    Published in:
    Clinical Rheumatology, 2020, v. 39, n. 9, p. 2563, doi. 10.1007/s10067-020-05015-5
    By:
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Maeda, Yuichi;
    • Yamamoto, Wataru;
    • Hashimoto, Motomu;
    • Murata, Koichi;
    • Takeuchi, Tohru;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yamamoto, Keiichi;
    • Kumanogoh, Atsushi;
    • Hirao, Makoto
    Publication type:
    Article
    29

    Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort.

    Published in:
    Arthritis Research & Therapy, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13075-025-03541-8
    By:
    • Fujii, Takayuki;
    • Murata, Koichi;
    • Kohjitani, Hirohiko;
    • Onishi, Akira;
    • Murakami, Kosaku;
    • Tanaka, Masao;
    • Yamamoto, Wataru;
    • Nagai, Koji;
    • Yoshikawa, Ayaka;
    • Etani, Yuki;
    • Okita, Yasutaka;
    • Yoshida, Naofumi;
    • Amuro, Hideki;
    • Okano, Tadashi;
    • Ueda, Yo;
    • Okano, Takaichi;
    • Hara, Ryota;
    • Hashimoto, Motomu;
    • Morinobu, Akio;
    • Matsuda, Shuichi
    Publication type:
    Article
    30
    31

    The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study

    Published in:
    Rheumatology International, 2020, v. 40, n. 2, p. 217, doi. 10.1007/s00296-019-04464-9
    By:
    • Murata, Koichi;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Nagai, Koji;
    • Takeuchi, Tohru;
    • Katayama, Masaki;
    • Maeda, Yuichi;
    • Ebina, Kosuke;
    • Hara, Ryota;
    • Jinno, Sadao;
    • Onishi, Akira;
    • Murakami, Kosaku;
    • Tanaka, Masao;
    • Ito, Hiromu;
    • Mimori, Tsuneyo;
    • Matsuda, Shuichi
    Publication type:
    Article
    32
    33
    34

    Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study.

    Published in:
    Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1880-4
    By:
    • Ebina, Kosuke;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Hirano, Toru;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Onishi, Akira;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Yamamoto, Keiichi;
    • Maeda, Yuichi;
    • Murata, Koichi;
    • Jinno, Sadao;
    • Takeuchi, Tohru;
    • Hirao, Makoto;
    • Kumanogoh, Atsushi;
    • Yoshikawa, Hideki
    Publication type:
    Article